Clinical trial

Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC

NCT01783197

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Selumetinib Normalized identity: selumetinibView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pemetrexed Normalized identity: pemetrexedView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-06-04

PhasePHASE1

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

PaclitaxelDRUG · verified · RxNorm: paclitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

SelumetinibDRUG · verified · RxNorm: selumetinib

PemetrexedDRUG · verified · RxNorm: pemetrexed

CisplatinDRUG · verified · RxNorm: cisplatin

Sponsors & collaborators

Canadian Cancer Trials Grouplead sponsor

AstraZenecacollaborator

Mapped research locations

VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 HamiltonOntario, Canada1 KingstonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01783197 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.